These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36463183)

  • 21. Patient and Provider Perspectives on a Novel, Low-Threshold HIV PrEP Program for People Who Inject Drugs Experiencing Homelessness.
    Bazzi AR; Shaw LC; Biello KB; Vahey S; Brody JK
    J Gen Intern Med; 2023 Mar; 38(4):913-921. PubMed ID: 35614171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Service utilization and cost of implementing a comprehensive HIV prevention and care program among people who inject drugs in Delhi, India.
    Sebastian MP; Dasgupta A; Saraswati LR; Singh A; Sharma V; Madan I; Tun W; Pulerwitz J; Thior I; Sarna A
    Harm Reduct J; 2017 Jun; 14(1):38. PubMed ID: 28615077
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Perspectives on HIV pre-exposure prophylaxis (PrEP) utilization and related intervention needs among people who inject drugs.
    Biello KB; Bazzi AR; Mimiaga MJ; Biancarelli DL; Edeza A; Salhaney P; Childs E; Drainoni ML
    Harm Reduct J; 2018 Nov; 15(1):55. PubMed ID: 30419926
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of COVID-19 on New York State's Drug User Health Hubs and syringe service programs: a qualitative study.
    Ude M; Behrends CN; Kelly S; Schackman BR; Clear A; Goldberg R; Gelberg K; Kapadia SN
    Harm Reduct J; 2023 Feb; 20(1):12. PubMed ID: 36732773
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-exposure prophylaxis (PrEP) for HIV prevention among people who inject drugs: a global mapping of service delivery.
    Shaw G; Schaefer R; Schmidt HA; Madden A; Chang J; Mozalevskis A; Msimanga-Radebe B; Mangadan Konath N; Verster A; Baggaley R; Rodolph M; Macdonald V
    Harm Reduct J; 2023 Feb; 20(1):16. PubMed ID: 36782321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Syringe disposal among people who inject drugs before and after the implementation of a syringe services program.
    Levine H; Bartholomew TS; Rea-Wilson V; Onugha J; Arriola DJ; Cardenas G; Forrest DW; Kral AH; Metsch LR; Spencer E; Tookes H
    Drug Alcohol Depend; 2019 Sep; 202():13-17. PubMed ID: 31280002
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expanding Access to Oral Preexposure Prophylaxis for People Who Inject Drugs in Bayelsa and Niger States, Nigeria.
    Nishimoto L; Ikani P; Achanya J; Idowu A; Olisa AL; Walker CF; Gottlieb A; Akolo C
    Glob Health Sci Pract; 2023 Feb; 11(1):. PubMed ID: 36853631
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interest in linkage to PrEP among people who inject drugs accessing syringe services; Miami, Florida.
    Jo Y; Bartholomew TS; Doblecki-Lewis S; Rodriguez A; Forrest DW; Tomita-Barber J; Oves J; Tookes HE
    PLoS One; 2020; 15(4):e0231424. PubMed ID: 32298320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Limited Knowledge and Mixed Interest in Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
    Bazzi AR; Biancarelli DL; Childs E; Drainoni ML; Edeza A; Salhaney P; Mimiaga MJ; Biello KB
    AIDS Patient Care STDS; 2018 Dec; 32(12):529-537. PubMed ID: 30311777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HIV and Addiction Services for People Who Inject Drugs: Healthcare Provider Perceptions on Integrated Care in the U.S. South.
    Bradford D; Parman M; Levy S; Turner WH; Li L; Leisch L; Eaton E; Crockett KB
    J Prim Care Community Health; 2023; 14():21501319231161208. PubMed ID: 36941754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Factors Associated with Sterile Syringe Acquisition among People Who Inject Drugs in West Virginia.
    Allen ST; Mazhnaya A; O'Rourke A; White RH; Wedlock P; Grieb SM; Kilkenny ME; Walls M; Sherman SG
    Subst Use Misuse; 2021; 56(12):1776-1784. PubMed ID: 34311667
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Medical Providers and Harm Reduction Views on Pre-Exposure Prophylaxis for HIV Prevention Among People Who Inject Drugs.
    Hershow RB; Gonzalez M; Costenbader E; Zule W; Golin C; Brinkley-Rubinstein L
    AIDS Educ Prev; 2019 Aug; 31(4):363-379. PubMed ID: 31361517
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Application of machine learning algorithms for localized syringe services program policy implementation - Florida, 2017.
    Bartholomew TS; Tookes HE; Spencer EC; Feaster DJ
    Ann Med; 2022 Dec; 54(1):2137-2150. PubMed ID: 35900201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Implementation of Syringe Services Programs to Prevent Rapid Human Immunodeficiency Virus Transmission in Rural Counties in the United States: A Modeling Study.
    Goedel WC; King MRF; Lurie MN; Galea S; Townsend JP; Galvani AP; Friedman SR; Marshall BDL
    Clin Infect Dis; 2020 Mar; 70(6):1096-1102. PubMed ID: 31143944
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stuck in the window with you: HIV exposure prophylaxis in the highest risk people who inject drugs.
    Taylor JL; Walley AY; Bazzi AR
    Subst Abus; 2019; 40(4):441-443. PubMed ID: 31644387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A cross-sectional study of the feasibility of pharmacy-delivered harm reduction services among people who inject drugs in Xichang, China.
    Yang Y; Latkin CA; Luan R; Yang C
    BMC Public Health; 2015 Sep; 15():885. PubMed ID: 26370245
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Living at the Confluence of Stigmas: PrEP Awareness and Feasibility Among People Who Inject Drugs in Two Predominantly Rural States.
    Carter G; Meyerson B; Rivers P; Crosby R; Lawrence C; Cope SD; DeBruicker D; Levin S; Meeks W; Thomas C; Turner B; Abert C; Coles H; Allen A; Gonzalez-Fagoaga E; Grivois-Shah R
    AIDS Behav; 2021 Oct; 25(10):3085-3096. PubMed ID: 34003385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nurse Practitioner-Led Integrated Rapid Access to HIV Prevention for People Who Inject Drugs (iRaPID): Protocol for a Pilot Randomized Controlled Trial.
    Khati A; Altice FL; Vlahov D; Eger WH; Lee J; Bohonnon T; Wickersham JA; Maviglia F; Copenhaver N; Shrestha R
    JMIR Res Protoc; 2022 Oct; 11(10):e42585. PubMed ID: 36222826
    [TBL] [Abstract][Full Text] [Related]  

  • 39. PrEP Care Continuum Engagement Among Persons Who Inject Drugs: Rural and Urban Differences in Stigma and Social Infrastructure.
    Walters SM; Frank D; Van Ham B; Jaiswal J; Muncan B; Earnshaw V; Schneider J; Friedman SR; Ompad DC
    AIDS Behav; 2022 Apr; 26(4):1308-1320. PubMed ID: 34626265
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reduction of Injection-Related Risk Behaviors After Emergency Implementation of a Syringe Services Program During an HIV Outbreak.
    Patel MR; Foote C; Duwve J; Chapman E; Combs B; Fry A; Hall P; Roseberry J; Brooks JT; Broz D
    J Acquir Immune Defic Syndr; 2018 Apr; 77(4):373-382. PubMed ID: 29271829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.